How “location, location, location” can lead to “enforcement, enforcement, enforcement”
Retrieved on:
Friday, April 12, 2024
How “location, location, location” can lead to “enforcement, enforcement, enforcement”
Key Points:
Register
EQS-News: Multitude SE: The Extraordinary General Meeting of Multitude SE Approved The Transfer Of The Company’s Registered Office From Finland To Malta
Retrieved on:
Wednesday, April 10, 2024
Additionally, the Extraordinary General Meeting approved certain other related proposals.
Key Points:
- Additionally, the Extraordinary General Meeting approved certain other related proposals.
- For the purposes of the Transfer, the Board of Directors had approved a Transfer Proposal (“Transfer Proposal”) in accordance with Article 8 (2) of the SE Regulation.
- Multitude’s Extraordinary General Meeting approved the Transfer Proposal (including, without limitation the New M&A), and resolved on the Transfer in accordance with the Transfer Proposal.
- The Extraordinary General Meeting resolved to appoint PricewaterhouseCoopers Malta as the auditor of the Company upon the registration of the Company with the Malta Business Registry.
EQS-News: NOTICE TO CONVENE MULTITUDE SE’S ANNUAL GENERAL MEETING OF SHAREHOLDERS
Retrieved on:
Wednesday, April 10, 2024
Appendix, Letter, Exercise, EEST, The Annual Report, Audit committee, Annual, Audit, Annual general meeting, Remuneration, Report, Register, Person, PwC, Proxy, Book, Annual report, Chapter Five, Auditor, EUR, Chapter Ten, Frankfurt Stock Exchange, Notice, Address, KHT, Mass meeting, Treasury, ID, Malta Business Registry, Security (finance)
The Board of Directors proposes to the Annual General Meeting that, for the financial year 2023, a dividend of EUR 0.19 per share be distributed.
Key Points:
- The Board of Directors proposes to the Annual General Meeting that, for the financial year 2023, a dividend of EUR 0.19 per share be distributed.
- Shareholders, who are registered in the shareholders’ register of the Company, and who wish to participate in the General Meeting, must register for the meeting by giving prior notice of participation as instructed below.
- Shareholders may participate in the General Meeting of Shareholders and exercise their rights at the meeting by way of proxy representation.
- On the date of this notice to the Annual General Meeting of Shareholders, dated 28 March 2024, the total number of shares in Multitude SE is 21,723,960 and each of these shares carries one vote.
SEC Adopts Reforms Relating to Investment Advisers Operating Exclusively Through the Internet
Retrieved on:
Wednesday, March 27, 2024
Washington, D.C.--(Newsfile Corp. - March 27, 2024) - The Securities and Exchange Commission today adopted amendments to the rule permitting certain internet investment advisers to register with the Commission (the “internet adviser exemption”).
Key Points:
- Washington, D.C.--(Newsfile Corp. - March 27, 2024) - The Securities and Exchange Commission today adopted amendments to the rule permitting certain internet investment advisers to register with the Commission (the “internet adviser exemption”).
- The amendments will require an investment adviser relying on the internet adviser exemption to have at all times an operational interactive website through which the adviser provides digital investment advisory services on an ongoing basis to more than one client.
- “These amendments modernize a 22-year-old rule to better protect investors in a digital age,” said SEC Chair Gary Gensler.
- Most investment advisers will have filed their annual updating amendments to Form ADV by this date i.e., 90 days after the Dec. 31, 2024, fiscal year end).
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ventyx, and Anavex and Encourages Investors to Contact the Firm
Retrieved on:
Tuesday, April 9, 2024
The Company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease.
Key Points:
- The Company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease.
- In addition, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.
- On November 6, 2023, during after-market hours, Ventyx issued a press release announcing results from the Phase 2 SERENITY Trial.
- For more information on the Anavex class action go to: https://bespc.com/cases/AVXL
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in HireRight Holdings Corporation of Class Action Lawsuit and Upcoming Deadlines – HRT
Retrieved on:
Monday, April 8, 2024
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against HireRight Holdings Corporation (“HireRight” or the “Company”) (NYSE: HRT) and certain officers.
Key Points:
- NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against HireRight Holdings Corporation (“HireRight” or the “Company”) (NYSE: HRT) and certain officers.
- To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext.
- Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
- Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – VTYX
Retrieved on:
Monday, April 8, 2024
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX) and certain officers.
Key Points:
- NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX) and certain officers.
- To discuss this action, contact Danielle Peyton at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
- Ventyx is a clinical-stage biopharmaceutical company that develops small-molecule product candidates to address a range of inflammatory diseases.
- Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Has Filed A Securities Fraud Class Action Lawsuit Against agilon health, inc.
Retrieved on:
Saturday, April 6, 2024
RADNOR, Pa., April 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
Key Points:
- RADNOR, Pa., April 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
- The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
- Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
- The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hut 8, Ventyx, and Anavex and Encourages Investors to Contact the Firm
Retrieved on:
Friday, April 5, 2024
In November 2023, Hut 8 formed following the merger of Hut 8 Mining Corp. (“Legacy Hut”) and U.S. Data Mining Group, Inc. d/b/a US Bitcoin Corp. (“USBTC”) (the “Merger”).
Key Points:
- In November 2023, Hut 8 formed following the merger of Hut 8 Mining Corp. (“Legacy Hut”) and U.S. Data Mining Group, Inc. d/b/a US Bitcoin Corp. (“USBTC”) (the “Merger”).
- USBTC held a 50% interest in a joint venture bitcoin mining facility, located in King Mountain, Texas (the “King Mountain JV”), which was acquired in the Merger.
- In addition, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.
- For more information on the Anavex class action go to: https://bespc.com/cases/AVXL
HRT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that HireRight Holdings Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Retrieved on:
Thursday, April 4, 2024
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against HireRight Holdings Corporation (“HireRight” or “the Company”) (NYSE: HRT) and certain of its officers.
Key Points:
- NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against HireRight Holdings Corporation (“HireRight” or “the Company”) (NYSE: HRT) and certain of its officers.
- or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
- If you suffered a loss in HireRight you have until June 3, 2024, to request that the Court appoint you as lead plaintiff.
- Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.